Thursday, December 2, 2021

In Play

These stocks could be In Play. Add them to your watch list.

The One Factor That May Distinguish Can-Fite BioPharma (CANF)

This is a play on the treatment of Covid-19 rather than a preventative vaccine Before the pandemic, one of the flagship drugs under the Can-Fite pipeline was Piclidenoson. An orally administered drug, Piclidenoson is essentially a small-molecule inhibitor that targets enzymes that cause inflammation.

Your Step-by-Step Guide to Investing in Australian Stocks

It’s a big world out there. While investors should maintain their core holdings in strong, U.S.-based companies with reasonable growth and earnings trajectories, the...

Small-Cap Gold and Silver Stocks to Buy to Profit from the Crisis

Due to the unprecedented crisis that is the novel coronavirus pandemic, investors are scrambling for the best sector in which to protect their money....

Could COVID-19 Concerns Be Helping To Drive Sales of Glucose Health’s (OTC Pink: GLUC)...

As more information becomes available pertaining to the Coronavirus pandemic and the association with certain pre-existing medical conditions, health experts are growing concerned about...

5 Pandemic Stocks to Buy That Are Off the Beaten Path

With the dramatic changes inherent in the novel coronavirus pandemic, it was no surprise that virtually all investment sectors tumbled in the immediate aftermath....

CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street

It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is something very...

Xalles Holdings Inc. (XALL) Growing Through Synergistic Acquisitions

Xalles Holdings (OTC: XALL), a financial technology holdings company, led by CEO Thomas Nash, has been the poster child for future CEO’s to mirror their...

STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)

The feline has attacked CytoDyn Inc. (OTCMKTS: CYDY) nine times within the last 8 months in an attempt to discredit the company as CYDY...

The Declaration of Independence of the Multistate Association of Sane Kinfolk.

That the market rose this week didn't surprise me. But, with the Bergman Buy Index up over 65% last week since we started in...

Misleading Headline on CydoDyn (CYDY) Triggers Algo Selling

Top short seller Andrew Left from Citron Research facilitated a bear raid led by Tim Sykes and his army of smaller short sellers, and eventually Adam Feuerstein chimed...

Latest News